These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

549 related items for PubMed ID: 12673731

  • 1. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    Cancer; 2003 Apr 15; 97(8):2006-12. PubMed ID: 12673731
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Apr 15; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP.
    J Clin Oncol; 2006 Jun 20; 24(18):2879-84. PubMed ID: 16782927
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882.
    J Clin Oncol; 2004 Jul 01; 22(13):2691-700. PubMed ID: 15226336
    [Abstract] [Full Text] [Related]

  • 8. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A.
    Cancer; 2002 Feb 15; 94(4):1111-20. PubMed ID: 11920482
    [Abstract] [Full Text] [Related]

  • 9. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
    Chau GY, Lui WY, Tsay SH, Chao Y, King KL, Wu CW.
    Ann Surg Oncol; 2006 Oct 15; 13(10):1329-37. PubMed ID: 16897271
    [Abstract] [Full Text] [Related]

  • 10. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL, Anderson J, Pappo AS, Meyer WH, Children's Oncology Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3844-51. PubMed ID: 16921036
    [Abstract] [Full Text] [Related]

  • 11. Adult type vs. Childhood hepatocellular carcinoma--are they the same or different lesions? Biology, natural history, prognosis, and treatment.
    Czauderna P.
    Med Pediatr Oncol; 2002 Nov 20; 39(5):519-23. PubMed ID: 12228910
    [Abstract] [Full Text] [Related]

  • 12. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY, Cheong JY, Cho SW, Sim SJ, Kim JS, Choi SJ, Choi JW, Kwon HC, Lee KM, Kim JK, Won JH, Yoo BM, Lee KJ, Hahm KB, Kim JH.
    Korean J Hepatol; 2006 Mar 20; 12(1):65-73. PubMed ID: 16565607
    [Abstract] [Full Text] [Related]

  • 13. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
    Laver JH, Kraveka JM, Hutchison RE, Chang M, Kepner J, Schwenn M, Tarbell N, Desai S, Weitzman S, Weinstein HJ, Murphy SB.
    J Clin Oncol; 2005 Jan 20; 23(3):541-7. PubMed ID: 15659500
    [Abstract] [Full Text] [Related]

  • 14. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S, Shimada M, Shirabe K, Maehara S, Harimoto N, Tsujita E, Sugimachi K, Maehara Y.
    Hepatogastroenterology; 2005 Jan 20; 52(63):862-5. PubMed ID: 15966221
    [Abstract] [Full Text] [Related]

  • 15. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
    von Schweinitz D, Bürger D, Weinel P, Mildenberger H.
    Klin Padiatr; 1992 Jan 20; 204(4):214-20. PubMed ID: 1381454
    [Abstract] [Full Text] [Related]

  • 16. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA, Pajak TF, Haulk TL, Flam M, Asbell SO.
    Cancer J Sci Am; 1998 Jan 20; 4(3):178-84. PubMed ID: 9612600
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T, Kimura T, Kurokawa F, Aoyama K, Ishikawa T, Tajima K, Yokoyama Y, Takami T, Omori K, Kawaguchi K, Tsuchiya M, Terai S, Sakaida I, Okita K.
    J Gastroenterol; 2005 Jan 20; 40(1):70-8. PubMed ID: 15692792
    [Abstract] [Full Text] [Related]

  • 18. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ.
    Ai Zheng; 2004 Aug 20; 23(8):933-8. PubMed ID: 15301718
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
    Yang TS, Chang HK, Chen JS, Lin YC, Liau CT, Chang WC.
    J Gastroenterol; 2004 Aug 20; 39(4):362-9. PubMed ID: 15168248
    [Abstract] [Full Text] [Related]

  • 20. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug 20; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.